Connection

GABRIEL HABIB to Hypertension

This is a "connection" page, showing publications GABRIEL HABIB has written about Hypertension.
Connection Strength

0.554
  1. Are there any new pharmacologic therapies on the horizon to better treat hypertension? A state-of-the-art paper. J Cardiovasc Pharmacol Ther. 2014 Nov; 19(6):516-25.
    View in: PubMed
    Score: 0.236
  2. Are calcium antagonists harmful in hypertensive patients? Distinguishing hype from reality. Chest. 1995 Jul; 108(1):3-5.
    View in: PubMed
    Score: 0.064
  3. Characteristics and long-term follow-up of participants with peripheral arterial disease during ALLHAT. J Gen Intern Med. 2014 Nov; 29(11):1475-83.
    View in: PubMed
    Score: 0.061
  4. Stroke outcomes among participants randomized to chlorthalidone, amlodipine or lisinopril in ALLHAT. J Am Soc Hypertens. 2014 Nov; 8(11):808-19.
    View in: PubMed
    Score: 0.060
  5. Mortality and morbidity during and after Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial: results by sex. Hypertension. 2013 May; 61(5):977-86.
    View in: PubMed
    Score: 0.055
  6. Outcomes in hypertensive black and nonblack patients treated with chlorthalidone, amlodipine, and lisinopril. JAMA. 2005 Apr 06; 293(13):1595-608.
    View in: PubMed
    Score: 0.031
  7. Cardiovascular outcomes using doxazosin vs. chlorthalidone for the treatment of hypertension in older adults with and without glucose disorders: a report from the ALLHAT study. J Clin Hypertens (Greenwich). 2004 Mar; 6(3):116-25.
    View in: PubMed
    Score: 0.029
  8. Reappraisal of the importance of heart rate as a risk factor for cardiovascular morbidity and mortality. Clin Ther. 1997; 19 Suppl A:39-52.
    View in: PubMed
    Score: 0.018
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.